A human-health risk assessment for West Nile virus and insecticides used in mosquito management

Environmental Health Perspectives

Volumn 114, Issue 3, 2006, Pages 366-372

  Peterson, Robert K D ^a   Macedo, Paula A ^a   Davis, Ryan S ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

Comparative risk assessment; Mosquito control; Organophosphates; Pesticide exposure; Pyrethroids; Risk analysis; Vectorborne disease

Indexed keywords

INSECTICIDE; MALATHION; NALED; ORGANOPHOSPHATE; PERMETHRIN; PESTICIDE; PHENOTHRIN; PIPERONYL BUTOXIDE; PYRETHRIN; PYRETHROID; RESMETHRIN;

ARTICLE; CANADA; COMPARATIVE STUDY; ENVIRONMENTAL EXPOSURE; EPIDEMIC; HEALTH HAZARD; HUMAN; MOSQUITO; NONHUMAN; PEST CONTROL; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; UNITED STATES; VIRUS VECTOR; WEST NILE FLAVIVIRUS;

ADULT; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INSECTICIDES; MALE; MODELS, THEORETICAL; MOSQUITO CONTROL; PESTICIDE SYNERGISTS; PIPERONYL BUTOXIDE; RISK ASSESSMENT; WEST NILE FEVER; WEST NILE VIRUS;

WEST NILE VIRUS;

EID: 33644765964     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8667     Document Type: Article

References (71)

1. AMVAC. 2003. Trumpet EC Insecticide. Material Safety Data Sheet. Los Angeles, CA:AMVAC Chemical Corporation.
2. Asnis DS, Conetta R, Waldman G, Teixeira AA. 2001. The West Nile virus encephalitis outbreak in the United States (1999-2000) - From Flushing, New York, to beyond its borders. Ann NY Acad Sci 951:161-171.
3. Bayer Environmental Science. 2004. Scourge Insecticide (4% + 12%). Material Safety Data Sheet. Montvale, NJ:Bayer Environmental Science.
4. Brilla R, Block M, Geremia G, Witcher M. 2004. Clinical and neuroradiological features of 39 consecutive cases of West Nile meningoencephalitis. J Neurol Sci 220:37-40.
5. CDC (Centers for Disease Control and Prevention). 1999. Outbreak of West Nile-like viral encephalitis: New York, 1999. MMWR Wkly Rep 48:845-849.
6. CDC. 2003. 2002 West Nile Virus Activity in the United States. Atlanta, GA:Centers for Disease Control and Prevention. Available: http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount02.htm [accessed 8 February 2005].
7. CDC. 2004a. 2003 West Nile Virus Activity in the United States. Atlanta, GA:Centers for Disease Control and Prevention. Available: http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount03_ detailed.htm [accessed 8 February 2005].
8. CDC. 2004b. West Nile Virus. Atlanta, GA:Centers for Disease Control and Prevention. Available: http://www.cdc.gov/ncidod/dvbid/westnile/index.htm [accessed 8 February 2005].
9. Clarke Mosquito Control Products. 1999a. Biomist 1.5+7.5 ULV. Material Safety Data Sheet. Roselle, IL:Clarke Mosquito Control Products, Inc.
10. Clarke Mosquito Control Products. 1999b. Anvil 2+2 ULV. Material Safety Data Sheet. Roselle, IL:Clarke Mosquito Control Products, Inc.
11. Cohen M. 2003. Poisoning the Big Apple. Synthesis/Regeneration 31(Spring). Available: http://www.greens.org/s-r/31/31-12.html [accessed 31 August 2005].
12. Cohen Hubal EA, Sheldon LS, Burke JM, McCurdy TR, Berry MR, Rigas ML, et al. 2000. Children's exposure assessment: a review of factors influencing children's exposure, and data available to characterize and assess that exposure. Environ Health Perspect 108:475-486.
13. Current JD. 1998. A linear equation for estimating the body surface area in infants and children. Internet J Anesthesiol 2(2). Available: http://www.ispub.com/journals/IJA/Vol2N2/bsa.htm/ [accessed 31 May 2005].
14. Currier M, McNeill M, Campbell D, Newton N, Marr JS, Newton N, et al. 2005. Human exposure to mosquito-control pesticides - Mississippi, North Carolina, and Virginia, 2002 and 2003. MMWR Wkly Rep 54:829-832.
15. Emig M, Apple DJ. 2003. Severe West Nile disease in healthy adults. Clin Infect Dis 38:289-292.
16. FAO. 2000. Pyrethrins. In: Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group. Geneva:World Health Organization and Food and Agricultural Organization, 685-749. Available: http://www.fao.org/ag/AGP/AGPP/Pesticid/JMPR/Download/2000_eva/ 16pyrethrins.pdf [accessed 2 February 2006].
17. Fehr-Snyder K. 2004. West Nile aerial spray unlikely: county panel recommends more ground fogging. The Arizona Republic (3 August). Available: http://www.azcentral.com/health/news/articles/0802westnile-ON.html [accessed 31 January 2006].
18. Fitz D. 2003. West Nile hysteria: the snake bite of 2002. Synthesis/Regeneration 31(Spring). Available: http://www.greens.org/s-r/31/31-13.html [accessed 31 August 2005].
19. Fletcher JS, Nellessen JE, Pfleeger TG. 1994. Literature review and evaluation of the EPA food-chain (Kenaga) nomogram, an instrument for estimating pesticide residues on plants. Environ Toxicol Chem 13:1383-1391.
20. Fratkin JD, Leis AA, Stokic DS, Slavinski SA, Geiss RW. 2004. Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med 128:533-537.
21. Freeman NCG, Hore P, Black K, Jimenez M, Sheldon L, Tulve N, et al. 2005. Contributions of children's activities to pesticide hand loadings following residential pesticide application. J Expo Anal Environ Epidemiol 15:81-88.
22. Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, et al. 2004. West Nile virus: where are we now? Lancet Infect Dis 4:547-556.
23. Griffin. 2001. Atrapa ULV. Material Safety Data Sheet. Valdosta, GA:Griffin LLC.
24. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. 2005. Epidemiology and transmission dynamics of West Nile Virus disease. Emerg Infect Dis 11:1167-1173.
25. Hayes EB, O'Leary DR. 2004. West Nile virus infection: a pediatric perspective. Pediatrics 113:1375-1381.
26. Hinten S. 2000. Staten Island Serosurvey. Available: http://www.cdc.gov/ncidod/dvbid/westnile/conf/pdf/2amiller.pdf [accessed 31 August 2005].
27. Hubalek Z. 2001. Comparative symptomatology of West Nile fever. Lancet Infect Dis 358:254-255.
28. Huhn GD, Sejvar JJ, Montgomery SP, Dworkin MS. 2003. West Nile virus in the United States: an update on an emerging infectious disease. Am Fam Physician 68:653-660.
29. Karpati AM, Perrin MC, Matte T, Leighton J, Schwartz J, Barr RG. 2004. Pesticide spraying for West Nile virus control and emergency department asthma visits in New York City, 2000. Environ Health Perspect 112:1183-1187.
30. Klee AL, Maldin B, Edwin B, Poshni I, Mostashari F, Fine A, et al. 2004. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10:1404-1411.
31. Knowles CO. 1991. Miscellaneous pesticides. In: Handbook of Pesticide Toxicology, Vol 2, Classes of Pesticides (Hayes WJ, Laws ER Jr, eds.). New York:Academic Press, Inc., 1471-1526.
32. Loeb M, Elliot SJ, Gibson B, Fearon M, Nosal R, Drebot M, et al. 2005. Protective behavior and West Nile virus risk. Emerg Infect Dis Available: http://www.cdc.gov/ncidod/EID/vol11no09/04-1184.htm [accessed 31 August 2005].
33. McLaughlin Gormley King. 2000. Pyrocide Fogging Concentrate 7126. Material Safety Data Sheet. Minneapolis, MN:McLaughlin Gormley King Co.
34. Mostashari F, Bunning ML, Singer DA, Nash D, Cooper MJ, Katz N, et al. 2001. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet Infect Dis 358:261-264.
35. Nash D, Labowitz A, Maldin B, Martin D, Mostashari F, Fine A, et al. 2001a. A follow-up study of persons infected with West Nile virus during a 1999 outbreak in the New York City area [Abstract]. Clin Infect Dis 33:1092.
36. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al. 2001b. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344:1807-1814.
37. NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC:National Academy Press.
38. NRC (National Research Council). 1996. Understanding Risk: Informing Decisions in a Democratic Society. Washington, DC:National Academy Press.
39. NYCDOH. 2001. Adult Mosquito Control Programs: Draft Environmental Impact Statement (DEIS). New York:New York City Department of Health. Available: http://www.ci.nyc.ny.us/html/doh/html/wnv/deis.html [accessed 31 August 2005].
40. O'Leary DR, Marfin AA, Montgomery SP, Kipp AM, Lehman JA, Biggerstaff BJ, et al. 2004. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 4:61-70.
41. O'Sullivan BC, Lafleur J, Fridal K, Hormozdi S, Schwartz S, Belt M, et al. 2005. The effect of pesticide spraying on the rate and severity of ED asthma. Am J Emerg Med 23:463-467.
42. Peleman RAAM. 2004. New and re-emerging infectious diseases: epidemics in waiting. Curr Opin Anaesthesiol 17:265-270.
43. Pepperell C, Rau N, Krajden S, Kern R, Humar A, Mederski B, et al. 2003. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 168:1399-1405.
44. Petersen LR, Marfin AA. 2002. West Nile virus: a primer for the clinician. Ann Intern Med 137:173-179.
45. Petersen LR, Marfin AA, Gubler DJ. 2003. West Nile Virus. JAMA 290:524-528.
46. Peterson RKD, Higley LG. 1993. Communicating pesticide risks. Am Entomol 39:206-211.
47. Saad M, Youssef S, Kirschke D, Shubair M, Haddadin D, Myers J, et al. 2005. Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection. J Infect 51:120-127.
48. Sampathkumar P. 2003. West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin Proc 78:1137-1144.
49. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, et al. 2003a. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290:511-515.
50. Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, et al. 2003b. Acute flaccid paralysis and West Nile infection. Emerg Infect Dis 9:788-793.
51. SETAC. 1994. Aquatic Dialogue Group: Pesticide Risk Assessment and Mitigation. Pensacola, FL:Society for Environmental Toxicology and Chemistry and SETAC Foundation for Environmental Education. Slovic P. 1987. Perception of risk. Science 236:280-285.
52. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. 1998. West Nile encephalitis epidemic in southeastern Romania. Lancet Infect Dis 352:1-5.
53. Tyler KL. 2001. West Nile Virus encephalitis in America. N Engl J Med 344:1858-1859.
54. USDA. 2005. The ARS Pesticide Properties Database. Beltsville, MD:U.S. Department of Agriculture, Agricultural Research Service. Available: http://www.ars.usda.gov/Services/docs.htm?docid=6433 [accessed 31 August 2005].
55. U.S. EPA. 1995. ISCST3. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/scram001/dispersion_screening.htm [accessed 31 August 2005].
56. U.S. EPA. 1996. Exposure Factors Handbook. Vol I. EPA/600/P-95/002Ba. Washington, DC:U.S. Environmental Protection Agency.
57. U.S. EPA (U.S. Environmental Protection Agency). 1997. Standard Operating Procedures (SOPs) for Residential Exposure Assessments. Draft. Available: http://www.epa.gov/pesticides/trac/science/trac6a05.pdf [accessed 31 August 2005].
58. U.S. EPA. 1998. PHED Surrogate Exposure Guide. Estimates of Worker Exposure from the Pesticide Handler Exposure Database Version 1.1. Washington, DC:U.S. Environmental Protection Agency.
59. U.S. EPA. 1999. AERMOD v. 1.0. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/scram001/dispersion_prefrec.htm#aermod [accessed 31 August 2005].
60. U.S. EPA. 2000a. Tox Oneliners for Resmethrin. Washington, DC:U.S. Environmental Protection Agency.
61. U.S. EPA. 2000b. Tox Oneliners for Sumithrin (Phenothrin). Washington, DC:U.S. Environmental Protection Agency.
62. U.S. EPA. 2000c. Memorandum from P. Deschamp, Health Effects Division, to P. Moe, Office of Prevention, Pesticides and Toxic Substances. Re: Malathion: Human Health Risk Assessment for the Reregistration Eligibility Decision (RED) Document, 22 September 2000. Washington, DC:U.S. Environmental Protection Agency.
63. U.S. EPA. 2002a. Interim Reregistration Eligibility Decision for Naled. EPA 738-R-02-008. Washington, DC:U.S. Environmental Protection Agency.
64. U.S. EPA. 2002b. Pesticides and Mosquito Control. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/pesticides/factsheets/pesticides4mosquitos.htm [accessed 31 August 2005].
65. U.S. EPA. 2005a. Memorandum from B Daiss, Health Effects Division, to C Rodia, Special Review and Registration. Re: Occupational and Residential Exposure Assessment and Recommendations for the Reregistration Elegibility Decision (RED) for Piperonyl Butoxide, 11 March 2005. Washington, DC:U.S. Environmental Protection Agency.
66. U.S. EPA. 2005b. Memorandum from T Dole, Health Effects Division, to C O'Connell, Special Review and Registration. Re: Pyrethrins: Revised Occupational and Residential Exposure Assessment and Recommendations for the Reregistration Elegibility Decision (RED) [PC Code 069001, DP Barcode D315957], 21 April 2005. Washington, DC:U.S. Environmental Protection Agency.
67. U.S. EPA. 2005c. Memorandum from SL Kinard, Y Yag, and S Ary, Health Effects Division, to J Guerry, Special Review and Reregistration Decision. Re: Permethrin: HED Chapter of the Reregistration Elegibility Decision Document (RED) [PC Code 109701, Case No. 52645-53-1, DP Barcode D319234], 19 July 2005. Washington, DC:U.S. Environmental Protection Agency.
68. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, et al. 2004. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 141:360-365.
69. Weinberger M, Pitlik SD, Gandacu D, Lang R, Nassar F, David DB, et al. 2001. West Nile Fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis 7:686-691.
70. Weiss D, Carr D, Kellachan J, Tan C, Philips M, Bresnitz E, et al. 2001. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 7:654-658.
71. Ziem G. 2005. Pesticide spraying and health effects [Letter]. Environ Health Perspect 113:A150.